Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2′Me-MPTP
- 1 February 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 146 (2-3) , 313-318
- https://doi.org/10.1016/0014-2999(88)90308-1
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adultsNeuroscience Letters, 1986
- Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeysAnnals of Neurology, 1986
- Persistent depletion of striatal dopamine in mice by 1-Methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine (MTTP)Biochemical Pharmacology, 1986
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- The Clinical Syndrome of Striatal Dopamine DeficiencyNew England Journal of Medicine, 1985
- Neurochemical and Histochemical Characterization of Neurotoxic Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine on Brain Catecholamine Neurones in the MouseJournal of Neurochemistry, 1985
- Is Parkinson’s Disease Acquired or Inherited?Canadian Journal of Neurological Sciences, 1984
- (-)-Deprenyl Leads to Prolongation of L-Dopa Efficacy in Parkinson s DiseasePublished by S. Karger AG ,1982
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979